Innoviva (INVA) Non-Current Deffered Revenue (2010 - 2017)

Innoviva (INVA) posted Non-Current Deffered Revenue of $1.6 million for Q3 2017, down 12.47% on a QoQ basis from $1.8 million in Q2 2017, and down 36.3% year-over-year from $2.4 million in Q3 2016.

Innoviva (INVA) Non-Current Deffered Revenue (2010 - 2017) Analysis & Trends

Innoviva's Non-Current Deffered Revenue history runs 8 years deep, the most recent figure standing at $1.6 million for Q3 2017.

  • Quarterly Non-Current Deffered Revenue fell 36.3% year-over-year to $1.6 million in Q3 2017, while the trailing twelve-month figure through Sep 2017 was $1.6 million (down 36.3% YoY) and the FY2016 annual result came in at $2.2 million, down 28.56% from the prior year.
  • Non-Current Deffered Revenue was $1.6 million for Q3 2017 at Innoviva, down from $1.8 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $5.7 million in Q1 2013 and bottomed at $13000.0 in Q2 2014.
  • A 5-year average of $2.8 million and a median of $2.7 million in 2016 frame the typical range for Non-Current Deffered Revenue.
  • Annual changes were most pronounced in 2014 — Non-Current Deffered Revenue plunged 99.72% — and 2016, when it surged 3133.71%.
  • Innoviva's Non-Current Deffered Revenue stood at $5.5 million in 2013, then tumbled by 30.56% to $3.8 million in 2014, then declined by 18.19% to $3.1 million in 2015, then dropped by 28.56% to $2.2 million in 2016, then retreated by 29.95% to $1.6 million in 2017.
  • Business Quant data shows INVA's Non-Current Deffered Revenue at $1.6 million in Q3 2017, $1.8 million in Q2 2017, and $2.0 million in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Innoviva 1.57 Bn 969.11 Mn 75.83 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 1.55 Mn
Jun 30, 2017 1.77 Mn
Mar 31, 2017 1.99 Mn
Dec 31, 2016 2.21 Mn
Sep 30, 2016 2.44 Mn
Jun 30, 2016 2.66 Mn
Mar 31, 2016 2.88 Mn
Dec 31, 2015 3.10 Mn
Sep 30, 2015 100,000.00
Jun 30, 2015 102,000.00
Mar 31, 2015 89,000.00
Dec 31, 2014 3.79 Mn
Sep 30, 2014 4.06 Mn
Jun 30, 2014 13,000.00
Mar 31, 2014 4.89 Mn
Dec 31, 2013 5.46 Mn
Sep 30, 2013 5.15 Mn
Jun 30, 2013 4.70 Mn
Mar 31, 2013 5.67 Mn
Dec 31, 2012 5.07 Mn